Chemistry of polyhalogenated nitrobutadienes, 17: Efficient synthesis of persubstituted chloroquinolinyl-1 H -pyrazoles and evaluation of their antimalarial, anti-SARS-CoV-2, antibacterial, and cytotoxic activities

A series of 26 novel 1-(7-chloroquinolin-4-yl)-4-nitro-1 -pyrazoles bearing a dichloromethyl and an amino or thio moiety at C3 and C5 has been prepared in yields up to 72% from the reaction of 1,1-bisazolyl-, 1-azolyl-1-amino-, and 1-thioperchloro-2-nitrobuta-1,3-dienes with 7-chloro-4-hydrazinylqui...

Full description

Saved in:
Bibliographic Details
Published inBeilstein journal of organic chemistry Vol. 18; pp. 524 - 532
Main Authors Zapol'skii, Viktor A, Berneburg, Isabell, Bilitewski, Ursula, Dillenberger, Melissa, Becker, Katja, Jungwirth, Stefan, Shekhar, Aditya, Krueger, Bastian, Kaufmann, Dieter E
Format Journal Article
LanguageEnglish
Published Germany 09.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A series of 26 novel 1-(7-chloroquinolin-4-yl)-4-nitro-1 -pyrazoles bearing a dichloromethyl and an amino or thio moiety at C3 and C5 has been prepared in yields up to 72% from the reaction of 1,1-bisazolyl-, 1-azolyl-1-amino-, and 1-thioperchloro-2-nitrobuta-1,3-dienes with 7-chloro-4-hydrazinylquinoline. A new way for the formation of a pyrazole cycle from 3-methyl-2-(2,3,3-trichloro-1-nitroallylidene)oxazolidine ( ) is also described. In addition, the antimalarial activity of the synthesized compounds has been evaluated in vitro against the protozoan malaria parasite . Notably, the 7-chloro-4-(5-(dichloromethyl)-4-nitro-3-(1 -1,2,4-triazol-1-yl)-1 -pyrazol-1-yl)quinoline ( ) and 7-chloro-4-(3-((4-chlorophenyl)thio)-5-(dichloromethyl)-4-nitro-1 -pyrazol-1-yl)quinoline ( ) inhibited the growth of the chloroquine-sensitive strain 3D7 with EC values of 0.2 ± 0.1 µM (85 ng/mL, 200 nM) and 0.2 ± 0.04 µM (100 ng/mL, 200 nM), respectively. Two compounds ( and ) have also been tested for anti-SARS-CoV-2, antibacterial, and cytotoxic activity.
ISSN:1860-5397
1860-5397
DOI:10.3762/bjoc.18.54